Public annual accounts

ANTHRACYT financials

Name: ANTHRACYT financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for ANTHRACYT, with comparable measures and links to available source documents.

Company overview

Registry number

0455427965

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for ANTHRACYT

2025 versus 2024

Operating line: €13,664
EBITDA: €10,437
Total assets: €391,449
Equity: €211,737

EBITDA margin +76.4% · Equity ratio +54.1%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Jun 2025	€13,664	€10,437	€391,449	€211,737	-
202430 Jun 2024	€14,749	€9,693	€423,568	€217,042	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report